R&D/ Views & Analysis/ Views and analysis Strength in numbers: Because having a rare disease isn’t rare mike.hammerton@pharmaphorum.com Deep Dive: R&D Innovation, Global Genes 0 Comment Rare doesn’t mean insignificant – in fact more people live with a rare disease than with cancer and Share X Strength in numbers: Because having a rare disease isn’t rare https://pharmaphorum.com/r-d/global-genes-rare-diseases/
R&D/ Views & Analysis/ Views and analysis The patient perspective on advocacy mike.hammerton@pharmaphorum.com Deep Dive: R&D Innovation, Inspire 0 Comment Growing up with the shadow of Huntington’s disease (HD) means Seth Rotberg understands the importance of peer support Share X The patient perspective on advocacy https://pharmaphorum.com/r-d/inspire-patient-advocacy-seth-rotberg/
R&D/ Views & Analysis/ Views and analysis How pharma can support doctors who treat rare diseases mike.hammerton@pharmaphorum.com Deep Dive: R&D Innovation, MedPanel 0 Comment Where do doctors see patients with rare diseases, how do they keep up with treatment advances and what Share X How pharma can support doctors who treat rare diseases https://pharmaphorum.com/r-d/orphan-drug-marketing-medpanel/
R&D/ Views & Analysis/ Views and analysis Living with LHON: Adapting to sight loss at 15 years old mike.hammerton@pharmaphorum.com Deep Dive: R&D Innovation, Santhera 0 Comment When faced with a devastating diagnosis, a family has two choices – to give up or make it Share X Living with LHON: Adapting to sight loss at 15 years old https://pharmaphorum.com/r-d/living-lhon-sight-loss-santhera/
R&D/ Views & Analysis/ Views and analysis A lifeline for rare disease patients mike.hammerton@pharmaphorum.com Alexion, Deep Dive: R&D Innovation 0 Comment For more than 25 years Alexion has been blazing a trail in rare diseases, bringing a series of Share X A lifeline for rare disease patients https://pharmaphorum.com/r-d/alexion-sean-richardson-charles-de-wet/
R&D/ Views & Analysis/ Views and analysis Realising the potential of wearable tech mike.hammerton@pharmaphorum.com Deep Dive: R&D Innovation, Spire Health 0 Comment Spire Health, a US-based continuous respiration sensing and high-adherence ambulatory monitoring healthcare company, is poised to revolutionise the Share X Realising the potential of wearable tech https://pharmaphorum.com/r-d/spire-health-clinical-trial-wearables/
R&D/ Views & Analysis/ Views and analysis Precision medicine: AZ’s Ruth March on its next steps mike.hammerton@pharmaphorum.com AstraZeneca, Deep Dive: R&D Innovation 0 Comment AstraZeneca’s senior vice-president and head of precision medicine, research & development, Ruth March, has been central to the Share X Precision medicine: AZ’s Ruth March on its next steps https://pharmaphorum.com/r-d/astrazeneca-ruth-march-precision-medicine/
R&D/ Views & Analysis/ Views and analysis Innovating in clinical trial recruitment mike.hammerton@pharmaphorum.com Deep Dive: R&D Innovation, Havas Lynx Faze 0 Comment Clinical trial recruitment is in crisis, with 80% of trials failing to recruit the required number of patients Share X Innovating in clinical trial recruitment https://pharmaphorum.com/r-d/havas-lynx-faze-clinical-trials/
R&D/ Views & Analysis/ Views and analysis Company profile: IDEA Pharma mike.hammerton@pharmaphorum.com Deep Dive: R&D Innovation, Idea Pharma 0 Comment We are in the most competitive period ever for the pharmaceutical industry, characterised by incremental innovation and looming Share X Company profile: IDEA Pharma https://pharmaphorum.com/r-d/idea-pharma-strategy/
